Prostatype Genomics AB Logo

Prostatype Genomics AB

Provides a genetic test to assess prostate cancer aggressiveness and guide treatment choices.

PROGEN | ST

Overview

Corporate Details

ISIN(s):
SE0022574554 (+2 more)
LEI:
549300JO6MPCGPVHVU91
Country:
Sweden
Address:
Gustav III:s Boulevard 34, 169 73 Solna
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Prostatype Genomics AB specializes in the development, manufacturing, and marketing of the prognostic genetic test, Prostatype®. The test is designed to provide a comprehensive assessment of the aggressiveness of diagnosed prostate cancer, particularly for patients with localized disease. It serves as a decision-making tool for clinicians and patients to help determine appropriate treatment strategies. The Prostatype® system uses existing biopsy tissue to analyze the expression of three key genes. This genetic data is combined with standard clinical parameters (PSA, Gleason Score, Tumor Stage) to calculate a proprietary P-score, which quantifies the risk of cancer mortality. By offering a more precise prognosis, the test aims to minimize both over- and under-treatment, thereby improving patient quality of life and saving healthcare resources.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Prostatype Genomics AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Prostatype Genomics AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Prostatype Genomics AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Sds Optic Spolka Akcyjna Logo
Develops fiber-optic diagnostic tech for real-time, in-vivo cancer biomarker analysis.
Poland
SDS
Seer, Inc. Logo
Provides researchers a platform for deep, unbiased, large-scale access to the proteome.
United States of America
SEER
Selvita S.A. Logo
Preclinical CRO offering integrated drug discovery and development services for life sciences.
Poland
SLV
SensoDetect AB Logo
AI tool providing objective ADHD & autism diagnosis via brain response to sound.
Sweden
SDET
Sensorion Logo
Developing gene therapies and small molecules to restore, treat, and prevent hearing loss.
France
ALSEN
Senti Biosciences, Inc. Logo
Developing smart cell and gene therapies with Gene Circuits to precisely target cancer.
United States of America
SNTI
SeouLinBioscienceCO.,LTD. Logo
South Korea
038070
Septerna, Inc. Logo
Advancing novel small molecule GPCR medicines for endocrine, immune, and metabolic diseases.
United States of America
SEPN
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. Logo
A contract research organization providing preclinical and clinical services for medical industries.
Japan
2395
Silence Therapeutics plc Logo
Develops RNAi therapies that silence disease genes for rare and underserved conditions.
United States of America
SLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.